# Implications and Stability of Clinical and Molecular Phenotypes of Severe Asthma

> **NCT01748175** · — · COMPLETED · sponsor: **Sally E. Wenzel MD** · enrollment: 715 (actual)

## Conditions studied

- Asthma
- Severe Persistent Asthma

## Interventions

- **DRUG:** Triamcinolone Acetonide

## Key facts

- **NCT ID:** NCT01748175
- **Lead sponsor:** Sally E. Wenzel MD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2021-12
- **Final completion:** 2022-01
- **Target enrollment:** 715 (ACTUAL)
- **Last updated:** 2022-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01748175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01748175, "Implications and Stability of Clinical and Molecular Phenotypes of Severe Asthma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01748175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*